Coronavirus

An ear sensor successfully alerted doctors to signs that COVID-19 patients isolating at home were getting worse and should be hospitalized.

A pill to treat COVID-19 that cut hospitalizations and deaths in half could become the first oral medication against the disease.

The FDA-approved antiviral drug remdesivir prevents high-risk people from ending up in the hospital, if given early.

The FDA has expanded its authorization of COVID-19 boosters of Pfizer’s vaccine to include seniors and people in high-risk populations.

New trial results suggest Pfizer’s COVID-19 vaccine works in kids between the ages of 5 and 11, safely triggering a robust antibody response.

Moderna is developing a combination vaccine to protect against COVID-19, seasonal influenza, and respiratory syncytial virus.

A large COVID-19 booster shot study in Israel found that a third dose significantly increased seniors’ protection against the coronavirus.

Responding to the variant’s rise, UK researchers are growing the Delta variant for trials.

A newly discovered antibody can neutralize all strains of COVID-19 and every other sarbecovirus known to infect humans.

An antibody cocktail developed by biopharmaceutical company AstraZeneca was highly effective at preventing symptomatic COVID-19 infections.